WayPoint Biomedical licenses over-the-counter fertility product

By E. Janene Geiss

Philadelphia, May 11 - WayPoint Biomedical, Inc. said Thursday that it has signed an letter of intent with Rochester, N.Y.-based Arben Biosciences to enter into an exclusive North American licensing agreement for their new product, Simplicity, The "No-Step" Pregnancy Test.

Under terms of the agreement Arben will provide copies of all required information related to the over-the-counter "No-Step" Pregnancy Cup Device necessary to effectively market the product, including technical support files, clinical data, regulatory status and studies.

WayPoint said it will evaluate the sales, marketing, regulatory and distribution potential for the Simplicity product in the $200 million U.S. over-the-counter retail pregnancy kit sector.

WayPoint, a wholly owned subsidiary of Huntington Beach, Calif.-based WayPoint Biomedical Holdings, Inc., is a biomedical technology firm, specializing in diagnostic tests and devices for screening and monitoring human health, fitness and environment.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.